Contract Pharmacal Corp.: Setting a New Paradigm in CDMO
pharmatechoutlook

Contract Pharmacal Corp.: Setting a New Paradigm in CDMO

Follow Contract Pharmacal Corp. on :

Paul Hennessey, Senior Vice President Sales & Business Development, Contract Pharmacal Corp.Paul Hennessey, Senior Vice President - Sales & Business Development
While the quest for innovative drugs picks up steam among leading pharmaceutical organizations, contract development and manufacturing organizations (CDMOs) continue to be weighed down by diminishing operating efficiency and spiking drug manufacturing costs. Addressing these setbacks, Hauppauge-based Contract Pharmacal Corp. (CPC) has set a new paradigm in the CDMO industry as the most trusted market-leading provider of high-quality, affordable pharmaceutical and nutritional products. Since opening its doors in 1971, CPC—a second generation, family owned company operated by brothers Matthew and Mark Wolf—has been defining the standards of excellence that are critical to the health and well-being of communities. “Our owners have a consistent track record of reinvesting into the business with advanced technology and new equipment to keep us up-to-date and on the cutting edge of everything we need to be a leading CDMO,” begins Paul Hennessey, Senior Vice President of Sales and Business Development at Contract Pharmacal Corp.

With its manufacturing operations entirely based in the U.S., CPC’s core competency lies in developing, manufacturing, and packaging solid dose drugs—over the counter and prescription— that include tablets, capsules, powders, and dietary supplements to cater to their growing need in the global market. Hennessey adds, “While numerous companies in our industry choose to outsource their manufacturing, we excel at bringing unprecedented efficiency to the table by focusing solely on solid dose manufacturing.” In addition, CPC enables customers to enjoy the benefits of scale; “we now have two 400 cubic foot blenders that allow us to manufacture massive batches of up to 8,000 kilos.” As such, the company invariably helps customers reduce their manufacturing costs by increasing their batch sizes, allowing them to be more competitive in the market.
CPC has constantly delivered the highest quality of dosage form, all the way from chewable, orally-dissolving, swallowable, and bi-layer tablets to hard-shell capsules containing powders, pellets, or both. In terms of packaging, CPC provides an array of solutions comprising sachets, stick packs, bottles, pouches, vials, blisters, cartons, and more through its high-speed, fully automated packaging lines with in-line cartoning. “We are one of the few companies that are producing dietary supplements within the factories governed by cGMPs used for drug products,” Hennessey remarks. In one instance, a large pharmaceutical company approached CPC for a stick pack project with multiple doses including one at an extremely low fill weight. Drawing on their deep expertise in stick pack projects, CPC’s engineering, validation, and R&D teams collaborated with the client, and successfully assisted them with their exhibit batches within a tight schedule.

While numerous companies in our industry choose to outsource their manufacturing, we excel at bringing unprecedented efficiency to the table by focusing solely on solid dose manufacturing

Hennessey underscores that CPC helps clients save considerable time by performing their product testing within their internal laboratories. Added to that, CPC’s astute project management group with highly skilled professional project managers assists clients with unparalleled project management capabilities. From quoting an item, preparing a proposal, all the way through validation and commercial launch, CPC’s dedicated project managers track and monitor every single aspect to deliver a program on time and within budget. As a science-based development organization, the company also conducts cross-training between its R&D teams in India and the US, leveraging deep, analytical and formulation R&D to successfully drive projects.

Fostering a culture of collaboration, honesty, and accountability, CPC is committed to quality, efficiency, and service and considers clients' needs as the utmost priority. Currently, the company is going through a major expansion that will add additional capacity and new equipment in blending, granulation, tablet compression, encapsulation, and coding. Hennessey concludes, “We recently announced a $40 Mn investment in a new manufacturing facility to increase our capacity and be able to make 40 Mn doses a year.”

Contract Pharmacal Corp. News

Contract Pharmacal Corp Converts Three Of Their Hauppauge Buildings To Solar Energy With SUNation Solar Systems

HAUPPAUGE, N.Y., July 13, 2017 /PRNewswire/ -- Hauppauge-based pharmaceutical company, Contract Pharmacal Corp (CPC), is leading the way in renewable energy for Long Island businesses by converting three of their buildings in the Hauppauge Industrial Park to run on solar energy.



Contract Pharmacal Corp commissioned local solar installation company in Ronkonkoma, SUNation Solar Systems, to design 3 solar arrays for their buildings located at 135 Adams Avenue, 150 Commerce Drive, and 145 Oser Avenue, all in Hauppauge, totaling over 741,880 watts.



The new solar powered electricity-generating systems will be comprised of a combined 2,182 solar panels and will cover all of the available roof space on 3 of Contract Pharmacal Corp's production facilities. Although the total amount of electricity produced will only cover 10% of their total electricity consumption, it will amount to saving the company over $111,000 dollars per year in electricity costs.



"We're proud to see that Contract Pharmacal has made a commitment to clean, renewable energy, and we're honored to be helping them achieve their global sustainability goals," says SUNation co-founder and CEO, Scott Maskin.



"The leadership at CPC simply saw the value in solar as a smarter way to pay for electricity. These projects continue CPC's commitment to sustainable practices, as we worked with them to develop their first solar project back in 2014," says Stephen Owen, founder and president of Sol Alliance, CPC's solar owner's representative.



Speaking on their new solar initiative, Contract Pharmacal president Mark Wolf says, "We are always in the business of becoming more efficient in our operations, and this is an exciting project that will help us continue to fulfill our promise of delivering superior products at competitive pricing."